Financials
Income statement
| Fiscal date | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|
| Total reported revenue | 24.7B | 15.7B | 16.0B | 12.8B |
| Cost of revenue | 20.7B | 13.2B | 13.8B | 10.9B |
| Gross profit | 4.0B | 2.5B | 2.2B | 1.9B |
| Operating expense | ||||
| Research & development | 899M | 758M | 850M | 743M |
| Selling general and admin | 675M | 602M | 678M | 666M |
| Other operating expenses | — | — | — | — |
| Operating income | 2.5B | 1.1B | 712M | 524M |
| Non operating interest income | ||||
| Income | 221M | 183M | 182M | 217M |
| Expense | 260M | 212M | 215M | 213M |
| Other income expense | — | — | — | — |
| Pretax income | 2.8B | 1.3B | 510M | 838M |
| Tax provision | 420M | 312M | 329M | 286M |
| Net income | 2.4B | 938M | 181M | 552M |
| Basic EPS | — | 1.2 | 0.3 | 0.8 |
| Diluted EPS | — | 1.2 | 0.3 | 0.8 |
| Basic average shares | — | 792.7M | 793.1M | 788.1M |
| Diluted average shares | — | 792.7M | 793.1M | 789.3M |
| EBITDA | 4.1B | 2.0B | 1.5B | 1.6B |
| Net income from continuing op. | 2.4B | 938M | 181M | 552M |
| Minority interests | 17M | 45M | 49M | 43M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |